JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 11, 2003; DOI: 10.1124/jpet.102.048462


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.102.048462v1
305/2/615    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rathi, S.
Right arrow Articles by Rattan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rathi, S.
Right arrow Articles by Rattan, S.

Vol. 305, Issue 2, 615-624, May 2003

Functional and Molecular Characterization of beta -Adrenoceptors in the Internal Anal Sphincter

Sandeep Rathi, Shiva Kazerounian, Kuldip Banwait, Stephanie Schulz, Scott A. Waldman and Satish Rattan

Department of Medicine, Division of Gastroenterology and Hepatology (San.R., K.B., Sat.R.); and Clinical Pharmacology (S.K., S.S., S.A.W.), Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania

The purpose of the present study was to characterize different beta -adrenoceptors (beta -ARs) and determine their role in the spontaneously tonic smooth muscle of the internal anal sphincter (IAS). The beta -AR subtypes in the opossum IAS were investigated by functional in vitro, radioligand binding, Western blot, and reverse transcription-polymerase chain reaction (RT-PCR) studies. ZD 7114 [(S)-4-[2-hydroxy-3-phenoxypropylaminoethoxy]-N-(2-methoxyethyl)phenoxyacetamide], a selective beta 3-AR agonist, caused a potent and concentration-dependent relaxation of the IAS smooth muscle that was antagonized by the beta 3-AR antagonist SR 59230A [1-(2-ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]-(2S)-2-propanol hydrochloride]. Conversely, the IAS smooth muscle relaxation caused by beta 1- and beta 2-AR agonists (xamoterol and procaterol, respectively) was selectively antagonized by their respective antagonists CGP 20712 [(±)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate salt] and ICI 118551. Saturation binding of [125I]iodocyanopindolol to beta -AR subtypes revealed the presence of a high-affinity site (Kd1 = 96.4 ± 8.7 pM; Bmax1 = 12.5 ± 0.6 fmol/mg protein) and a low-affinity site (Kd2 = 1.96 ± 1.7 nM; Bmax2 = 58.7 ± 4.3 fmol/mg protein). Competition binding with selective beta -AR antagonists revealed that the high-affinity site correspond to beta 1/beta 2-AR and the low affinity site to beta 3-AR. Receptor binding data suggest the predominant presence of beta 3-AR over beta 1/beta 2-AR. Western blot studies identified beta 1-, beta 2-, and beta 3-AR subtypes. The presence of beta 1-, beta 2-, and beta 3-ARs was further demonstrated by mRNA analysis using RT-PCR. The studies demonstrate a comprehensive functional and molecular characterization of beta 1-, beta 2-, and beta 3-ARs in IAS smooth muscle. These studies may have important implications in anorectal and other gastrointestinal motility disorders.


0022-3565/03/3052-0615$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. A. Patel and S. Rattan
Spontaneously tonic smooth muscle has characteristically higher levels of RhoA/ROK compared with the phasic smooth muscle
Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G830 - G837.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Rouget, M. Bardou, M. Breuiller-Fouche, C. Loustalot, H. Qi, E. Naline, T. Croci, D. Cabrol, C. Advenier, and M. J. Leroy
{beta}3-Adrenoceptor Is the Predominant {beta}-Adrenoceptor Subtype in Human Myometrium and Its Expression Is Up-Regulated in Pregnancy
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1644 - 1650.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. F. de Godoy, A. M. de Oliveira, and S. Rattan
Angiotensin II-Induced Relaxation of Anococcygeus Smooth Muscle via Desensitization of AT1 Receptor, and Activation of AT2 Receptor Associated with Nitric-Oxide Synthase Pathway
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 394 - 401.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Li, M. De Godoy, and S. Rattan
Role of Adenylate and Guanylate Cyclases in {beta}1-, {beta}2-, and {beta}3-Adrenoceptor-Mediated Relaxation of Internal Anal Sphincter Smooth Muscle
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1111 - 1120.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. M. Kravtsov, I. S. S. Hwang, and F. Tang
The Inhibitory Effect of Adrenomedullin in the Rat Ileum: Cross-Talk with {beta}3-Adrenoceptor in the Serotonin-Induced Muscle Contraction
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 241 - 248.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.